Asymchem and Suzhou Ruiming Announce Strategic Collaboration on Ophthalmic Drug Development

According to ASYMCHEM's official WeChat, recently, Asymchem Laboratories (Tianjin) Co., Ltd. signed a strategic cooperation agreement with Suzhou Raymon Pharmaceuticals Company, Ltd. The two parties will carry out long-term in-depth strategic cooperation in the research and development/production services of ophthalmic new drugs to advance the drug R&D process. The scope of cooperation includes but is not limited to pharmaceutical R&D technical services, such as API and formulation process/prescription development and optimization, production, R&D and registration of new varieties, clinical sample supply and commercial supply, drug-related pharmacokinetic and toxicological studies, clinical service research, and one-stop services such as consultation on drug policies and regulations.